d) at AGC Biologics

Heidelberg, Baden-Württemberg, Germany

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, BiotechnologyIndustries

Requirements

Erfolgreich abgeschlossene Ausbildung als BTA/CTA/PTA etc. oder abgeschlossenes naturwissenschaftliches Studium
Fundierte Kenntnisse im Bereich der mikrobiellen Kultivierung von Bakterien und Hefen, sowie in der Handhabung von Fermentationsanlagen
Umfangreiche Kenntnisse in den relevanten Analysemethoden
Teamfähigkeit, Verantwortungs- und Qualitätsbewusstsein
Gute Englischkenntnisse
Flexibilität bei den Arbeitszeiten und Bereitschaft zur Schichtarbeit (montags bis freitags, 6:00 Uhr bis 22 Uhr)

Responsibilities

Konzeption, Vorbereitung, Durchführung und Dokumentation von Versuchen
Fermentationen im Labormaßstab
Mikrobiologische und molekularbiologische Arbeiten (u.a. Herstellung kompetenter Zellen, Transformation, Kultivierung von gentechnisch veränderten Mikroorganismen) sowie ggf. deren Dokumentation nach GenTG
Analytische Methoden (u.a. photometrische Methoden, SDS-PAGE, Western Blot)
Allgemeine Laborarbeiten: Aufrechterhaltung der Ordnung und Sauberkeit sowie Sicherheit im Labor, Sicherstellung der Verfügbarkeit von Rohstoffen und Verbrauchsmaterialien
Übernahme von Geräteverantwortlichkeiten: Sicherstellung der Funktionalität, Organisation von Wartungen und Reparaturen, ggf. Durchführung von Kalibriertätigkeiten
Teilnahme an internen Schulungen

Skills

Microbial Cultivation

High Cell Density Fermentation

Bioreactor Operation

Molecular Biology

Competent Cells Preparation

Transformation

GMO Cultivation

Photometric Methods

SDS-PAGE

Western Blot

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters

2001Year Founded

$613MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.

Leadership changes may disrupt ongoing projects and affect client trust.

Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.

The company offers fast-track project capabilities for orphan drugs and rare diseases.

AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.

Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.

Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI

Try Jobo Free